Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SIGA Technologies Inc. -- Ignore unavailable to you. Want to Upgrade?

To: caly who wrote (152)	11/28/2011 4:50:19 PM
From: Ernest K Brandt	Read Replies (1) \| Respond to of 160

SIGA Caly if it makes you feel any better I am in the same boat as you. I made a nice piece of change here but did leave too much on the table. Ernie

To: caly who wrote (152)	12/3/2011 11:50:24 PM
From: joseffy	Respond to of 160

news-medical.net "In June, 2007, ''Science'' magazine reported that an American soldier who had been vaccinated for smallpox, a vaccine that contains live vaccinia virus, had transmitted vaccinia virus to his two-year-old son. The soldier and his son both had a history of eczema. The son rapidly came down with a rare side effect, eczema vaccinatum, which had been seen during the 1960s when children were routinely vaccinated against smallpox. The child developed a severe full-body pustular rash, his abdomen filled with fluid, and his kidneys nearly failed. Intense consultation with experts from the Centers for Disease Control and Prevention and a donation of an experimental antiviral drug by SIGA Technologies saved the child's life." Los Angeles Times crap artist, David Willman[, in his assassin piece on SIGA NEVER MENTIONS THIS. He commits journalistic fraud by writing repeatedly that the SIGA drug has never been tested on humans.